{"id":"b71fe78e-432a-4aa4-b512-d5a2ac5ea2f5","arxiv_id":"2508.04743","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"high","formal_verification":"none","parameter_count":2,"one_line_summary":"Alz-QNet fits a variational quantum circuit to binarized Alzheimer's entorhinal-cortex gene-expression data, reading pairwise gene-interaction strengths from the fitted rotation angles.","lead":"This paper applies a quantum circuit model, Alz-QNet, to single-nucleus RNA-seq data from Alzheimer's patients to infer interactions among eight disease-linked genes. It claims to recover known regulatory links while using half the quantum gates of an existing gene-network model.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The claimed θx,y = θy,x symmetry is imposed by copying the upper triangle into the lower, not derived from the fitted full model; the 50% gate reduction and the inferred edges are therefore unsupported.","rationale":"I agree with the reader's weakest_assumption. The central novelty claim (Contribution 2) is the halving of CRY gates based on a symmetry that the paper never demonstrates—it simply enforces it. This is load-bearing because the gate reduction and the subsequent gene-interaction graph both depend on the symmetry being a true property of the optimal solution, not an arbitrary constraint. The suggested test directly checks whether the unconstrained model would also learn near-symmetric θ. If it does not, Alz-QNet is not an optimization of QGRN but a different, more constrained model whose biological conclusions may be artifacts. The paper's own proof-of-concept caveat (Sec 5.1) and the absence of error bars or classical baselines support the reader's REJECT verdict; my read does not change it.","tokens_in":10720,"tokens_out":5490,"duration_ms":63990,"concrete_test":"Reproduce the experiment using the original QGRN with all 56 CRY gates on the same 1,041-nucleus binarized dataset, with identical initialization and optimizer. After convergence, compute (i) the mean absolute difference |θ_x,y − θ_y,x| across all 28 pairs, and (ii) the KL divergence between the QGRN and Alz-QNet output distributions. If the asymmetry is not within the optimizer's numerical tolerance (e.g., MAE > 0.001 rad) or the KL divergence is non-negligible (>0.01), the symmetry is not an observed property and the gate-reduction claim fails.","verdict_should_be":"UNCHANGED","load_bearing_attack":"Contribution 2 and Sec 6.3 rest on 'θx,y = θy,x' being an observed property. But Sec 5.2 states the lower triangular matrix was 'constructed from the equal values of θx,y = θy,x' — i.e., after fitting only the upper triangle, the lower is copied. This is a constraint, not a finding. The Alz-QNet circuit is a different ansatz from QGRN (n(n−1)/2 vs n(n−1) gates), so a similar output distribution (Fig 4) is only a weak visual check; no quantitative fit metric is given. Consequently, the gate reduction is trivially true by construction, but the claim that it 'saves computations' without losing information needs validation against the unconstrained model. Moreover, since gene regulation is inherently directed, imposing symmetry can create spurious reciprocal edges or mask real directed interactions; the biological interpretations (e.g., YY1→PLD3) are parameters fitted to the observed binary distribution, not independent predictions. The paper even calls itself a proof-of-concept (Sec 5.1), but this only underscores the need for a baseline comparison.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper proposes Alz-QNet, a variational quantum circuit (VQC) that regresses a binarized gene-expression distribution derived from snRNA-seq entorhinal-cortex samples (GSE138852) for eight AD-related genes. The circuit uses one CRY gate per gene pair after imposing θx,y = θy,x, halving the n(n−1) gates of the earlier QGRN. The authors report a gene-interaction graph with activation/repression edges and interpret several edges (e.g., YY1 repressing PLD3) as biologically meaningful. Simulations in Qiskit show observed vs output frequency distributions for Alz-QNet and QGRN.","tokens_in":11025,"tokens_out":6495,"duration_ms":77941,"significance":"If valid, a quantum GRN method with halved circuit depth would be a useful step for NISQ-era QML in genomics, and the application to AD is timely. The paper is transparent about its proof-of-concept nature and gives a reasoned binarization protocol and a literature-support table. However, its central quantitative claim is not supported: the θ symmetry is imposed by construction, not learned, and the biological “predictions” are in-sample fitted parameters without error bars, baselines, or out-of-sample validation. The contribution is therefore currently more a circuit-architecture proposal than an established inference result.","major_comments":[{"comment":"The claimed observation θx,y = θy,x is not an empirical finding. The text states that the upper triangular matrix is the optimized theta and that the “lower triangular matrix was constructed from the equal values of θx,y = θy,x.” Thus the symmetry is imposed by copying, and the 50% gate reduction is true by construction. To support the scalability claim, the authors must fit the full QGRN with n(n−1) independent CRY angles on the same data and show (i) a comparable output distribution and (ii) that the symmetric optimum is not a local artifact. Without this, the assertion that half the gates “suffice” without altering the final quantum state is unsubstantiated.","section":"Sec. 5.2 / Contribution 2"},{"comment":"The reported “predictions” (e.g., YY1 represses PLD3, θ = −0.1129) are the fitted variational parameters, not predictions validated on unseen data. There is no train/test split, cross-validation, bootstrap, or uncertainty quantification. As a result, the biological conclusions are in-sample descriptions of the trained circuit. To claim the model “recovers biologically meaningful regulatory circuits,” the authors should evaluate on held-out nuclei or synthetic ground-truth networks and compare with classical GRN inference baselines (e.g., Pearson correlation, GENIE3, PIDC) using the same binarized data.","section":"Sec. 6.1 / Sec. 6.3"},{"comment":"“Similar probability distribution” is assessed only visually. No quantitative divergence or fit statistic is reported for Alz-QNet vs observed or QGRN vs observed. Given n = 8 qubits, the output space has 256 states and the observed distribution is sparse; visual agreement can be misleading. Report e.g. KL/JS divergence, total variation distance, or R² and include per-state residuals.","section":"Sec. 5.2 / Fig. 4"},{"comment":"Gene regulation is biologically directed. Imposing θx,y = θy,x forces every interaction to be symmetric, so the graph in Fig. 3 cannot represent directed regulation (activation/repression by a regulator of a target) without additional orientation information. The authors need to either justify the symmetry biologically or show that the fitted model is not missing directionality. Relatedly, a CRY gate is not symmetric under exchange of control and target; the matrix symmetry reported in Sec. 5.2 does not by itself imply the circuit structure is symmetric.","section":"Sec. 5.2 / Fig. 3 and symmetric ansatz"}],"minor_comments":[{"comment":"“CE microenvironment” should be “EC microenvironment”; gene names such as FGF14 and SREBF2 are inconsistently spaced throughout (e.g., “FGF 14”, “S REBF 2”).","section":"Abstract"},{"comment":"The caption says θ (X-axis) and ϕ1 (Y-axis) vary continuously, but each panel is for a different fixed value of ϕ1. Please clarify what is plotted in each heatmap and how the claimed symmetry is read from the figure.","section":"Fig. 5 caption"},{"comment":"The choice of binarization at a Pearson residual threshold of zero is reasonable, but its effect on the inferred network is not tested. A sensitivity analysis over nearby thresholds would strengthen the results.","section":"Sec. 5.1"},{"comment":"No code or data availability statement is provided. Since the paper relies on Qiskit simulations and a specific filtering pipeline, releasing code would materially improve reproducibility.","section":"Throughout"},{"comment":"The caption uses green/red edges for up/down regulation but the graph edges have no arrows. Please state explicitly whether edges are directed or undirected and how the sign is assigned.","section":"Fig. 3 caption"}],"recommendation":"reject","confidential_remarks":null},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Dear colleague,\n\nQuick take: Alz-QNet is a proof-of-concept application of a variational quantum circuit to eight AD-related genes, and it has a few nice pieces, but its centerpiece contribution—halving the CRY gates of QGRN by exploiting θx,y = θy,x—is not supported. Section 5.2 shows the lower triangle of the theta matrix was \"constructed from the equal values\" after fitting the upper triangle. That is an imposed ansatz, not an observed symmetry. The authors call it an observation in the contributions, which is misleading.\n\nWhat's genuinely new here is the application of QGRN-style quantum regression to entorhinal cortex snRNA-seq from GSE138852, with explicit gene selection and a supplementary table citing literature support for the predicted interactions. The circuit is described clearly, and the authors do compare Alz-QNet's output distribution to the original QGRN, which is more than many such papers do.\n\nThe soft spots are serious, though. The biological \"predictions\" are just the fitted θ values from a model trained to reproduce the binarized expression distribution. There's no held-out validation, no classical baseline (correlation, regression, etc.), no error bars, and no quantitative fit metric—the observed-vs-output plots in Fig. 4 are training fits. The claim that the symmetry saves computations \"without altering the final quantum state representation\" is not tested against the unconstrained model; you can't conclude information losslessness from an ansatz that imposes the symmetry. There are also exposition issues: the abstract calls FGF14 \"Sterol regulatory element binding transcription factor 14\" (that's SREBF2), and \"CE\" appears where \"EC\" is meant.\n\nThe paper's own framing as a proof-of-concept is fair, but even in that frame the central methodological claim needs a comparison. The fitted network might be interesting to an AD biologist as a hypothesis generator, but the reader shouldn't take the gate reduction or the interaction strengths at face value.\n\nRecommendation: I'd send this out for review rather than desk-reject, because the topic is timely and the flaw is fixable in principle. But the referee report would need to demand an unconstrained model comparison, a classical baseline, and a rewrite of the symmetry claim. If those aren't provided, reject. As it stands, this is a moderate-quality proof-of-concept with an overclaimed contribution.\n\nBest, [Your name]","headline":"The paper's main claim—halving QGRN gates because θx,y = θy,x—doesn't survive contact with Sec 5.2: the symmetry is imposed by copying the upper triangle, not observed, so the gate reduction and the inferred interactions are fitted artifacts.","tokens_in":11449,"tokens_out":4199,"would_cite":false,"duration_ms":50492,"reading_group":"no","serious_thinker":"no","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Alz-QNet claims a variational quantum circuit infers Alzheimer's gene-gene interactions from binarized entorhinal-cortex data using half the controlled-rotation gates of the standard quantum gene regulatory network.","keywords":["Alzheimer's disease","quantum regression","gene regulatory network","variational quantum circuit","gene-gene interaction","single-nucleus RNA-seq","entorhinal cortex","quantum machine learning"],"falsifier":"Fit the same eight-gene data with a circuit that keeps two independent angles per gene pair ($\\theta_{x,y}$ and $\\theta_{y,x}$); if the fitted asymmetries exceed the noise level for any pair, the symmetric one-gate-per-pair parametrization is omitting directional information and the claimed 50% gate reduction no longer represents the same interaction model.","tokens_in":10614,"feed_emoji":"🧠","tokens_out":8946,"duration_ms":93638,"temperature":0.7,"pith_summary":"This paper tries to establish that a quantum regression network can recover gene-gene regulatory relationships in Alzheimer's disease from binarized single-nucleus gene-expression data of the entorhinal cortex. The network, Alz-QNet, encodes eight AD-related genes as qubits and represents each pairwise interaction by one controlled rotation angle, relying on the claim that the interaction between two genes is symmetric ($\\theta_{x,y} = \\theta_{y,x}$). If that holds, the circuit needs only half the controlled-rotation gates of the standard quantum gene regulatory network, making the approach cheaper and more scalable. The fitted angles yield concrete predictions, such as YY1 repressing PLD3 and PLD3 repressing APP, which the paper uses to suggest therapeutic entry points. The key bet is that a symmetric pairwise interaction matrix is enough to capture the regulatory content.","feed_headline":"Alz-QNet halves quantum gates for Alzheimer's gene-network inference","feed_subtitle":"Circuit recovers regulatory edges among eight AD genes, predicting YY1 represses PLD3.","key_machinery":"The central object is the variational quantum circuit Alz-QNet: an encoding layer converts each nucleus's 8-bit activation state into qubit rotations (initialized with $\\theta = 2\\arcsin(\\sqrt{a_k})$ so each qubit's $|1\\rangle$ probability matches the gene's observed activation frequency), and a parameterized layer of CRY gates couples every pair of gene-qubits. Each fitted angle $\\theta_{x,y}$ is read as the strength of the interaction between genes $x$ and $y$. The load-bearing identity is $\\theta_{x,y} = \\theta_{y,x}$, which lets the paper use one CRY gate per unordered pair rather than two per ordered pair; the authors argue the resulting amplitude structure is unchanged, so the identica","core_discovery":"Alz-QNet is a variational quantum circuit that takes, for each nucleus, an 8-bit binarized expression profile of APP, SREBF2, EGR1, YY1, PLD3, GAS7, FGF14, and AKT3 and is trained so that its output distribution matches the observed frequency distribution of activation patterns across 1,041 AD-patient nuclei. The interaction between genes $x$ and $y$ is encoded by a controlled-Y rotation angle $\\theta_{x,y}$; the paper's central observation is that $\\theta_{x,y} = \\theta_{y,x}$, so the lower triangle of the interaction matrix can be filled by copying the fitted upper triangle, cutting the number of CRY gates from $n(n-1)$ to $n(n-1)/2$. With this reduction the model reproduces the QGRN basel","pith_inferences":["The paper leaves implicit that, because the lower triangle is copied from the upper triangle, the fitted matrix is symmetric by construction; the circuit cannot by itself distinguish 'gene A regulates gene B' from 'gene B regulates gene A', so directed statements like 'YY1 represses PLD3' lean on prior biology, not on the quantum fit alone.","A natural extension is to compare Alz-QNet's symmetric interaction strengths with a classical asymmetric GRN reconstruction on the same 1,041 nuclei; large discrepancies would localize where the symmetry assumption distorts the network.","The gate-halving argument is essentially a parameter-sharing claim and should transfer to any pairwise symmetric interaction model in quantum machine learning, not just gene regulation; the paper's heatmap analysis is a concrete instance of that general principle."],"forward_implications":["If Alz-QNet is right, quantum regression can recover the structure of a gene network from a few thousand binarized nuclei at half the circuit cost of the standard QGRN.","The predicted edges, YY1 repressing PLD3, PLD3 repressing APP, and EGR1 activating APP/SREBF2/GAS7, become concrete hypotheses that can be tested by knockdown or overexpression experiments.","The 50% reduction in controlled-rotation gates lowers the gate count for $n$ genes from $n(n-1)$ to $n(n-1)/2$, directly improving the scalability of quantum GRN inference on near-term hardware.","The alignment between predicted $\\theta$-values and independently documented mechanisms, such as APP activating SREBF2 and FGF14 repressing SREBF2, argues that the fitted angles carry biological signal rather than only fitting noise."],"supporting_citations":[{"why":"Provides the QGRN baseline circuit and the $n(n-1)$ controlled-rotation gate count that Alz-QNet halves; supplies the theta-initialization scheme.","marker":"Roman-Vicharra and Cai, 2023"},{"why":"Source of the GSE138852 single-nucleus RNA-seq entorhinal-cortex data from which the 1,041 AD nuclei and 8-gene binarized matrix are drawn.","marker":"Jovic et al., 2022"},{"why":"Supports modeling gene regulation as switch-like binary activation, the rationale for binarizing expression residuals.","marker":"Karlebach and Shamir, 2008"},{"why":"Establishes APP and amyloid processing as the central AD axis used to select genes and interpret predicted interactions.","marker":"Selkoe and Hardy, 2016"},{"why":"The transcriptomic/epigenetic portrait of AD brain that the paper invokes to argue the predicted network is biologically consistent.","marker":"Grubman et al., 2019"},{"why":"Independent evidence that APP overactivation upregulates SREBF2, used to validate the predicted APP-to-SREBF2 edge.","marker":"Barbero-Camps et al., 2013"},{"why":"Independent evidence that FGF14 signaling represses SREBF2, used to validate the predicted FGF14-to-SREBF2 edge.","marker":"Hsu et al., 2017"},{"why":"Independent evidence that PLD3 loss increases APP processing, used to validate the predicted PLD3-to-APP repressive edge.","marker":"Bottero et al., 2021"},{"why":"Evidence that EGR1 binds the APP promoter and increases amyloid production, used to validate the predicted EGR1-to-APP edge.","marker":"Qin et al., 2016"}],"fun_headline_variants":["Quantum circuit halves gates to map Alzheimer's gene network","Alz-QNet: fewer quantum gates, same gene interaction insights","Cutting quantum gates in half to trace AD gene regulation","Quantum net predicts YY1 suppresses PLD3 in Alzheimer's","Efficient quantum regression decodes eight-gene Alzheimer's wiring"],"cache_read_input_tokens":2816,"weakest_assumption_plain":"The load-bearing premise is that gene-gene interactions are pairwise symmetric, because the paper builds the lower triangle of the interaction matrix by copying the fitted upper-triangle values, and if the true regulatory relationships carry direction, the 50% gate reduction and the inferred edges would not follow.","fun_headline_variants_meta":{"raw":{"variants":["Quantum circuit halves gates to map Alzheimer's gene network","Alz-QNet: fewer quantum gates, same gene interaction insights","Cutting quantum gates in half to trace AD gene regulation","Quantum net predicts YY1 suppresses PLD3 in Alzheimer's","Efficient quantum regression decodes eight-gene Alzheimer's wiring"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000212,"raw_usage":{"total_tokens":1319,"prompt_tokens":875,"completion_tokens":444,"prompt_tokens_details":{"cached_tokens":256},"prompt_cache_hit_tokens":256,"prompt_cache_miss_tokens":619,"completion_tokens_details":{"reasoning_tokens":359}},"tokens_in":619,"tokens_out":444,"duration_ms":6258,"temperature":1.0,"reasoning_tokens":359,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-06T00:55:40.554240+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Fit the same eight-gene data with a circuit that keeps two independent angles per gene pair ($\\theta_{x,y}$ and $\\theta_{y,x}$); if the fitted asymmetries exceed the noise level for any pair, the symmetric one-gate-per-pair parametrization is omitting directional information and the claimed 50% gate reduction no longer represents the same interaction model.","supporting_citations":[{"cited_title":"The accumulation of peptides of Amyloid Beta ( Aβ) from APP is a crucial factor in the pathology of AD (Wang et al., 2018)","cited_arxiv_id":null,"evidence_quote":"The transcriptomic/epigenetic portrait of AD brain that the paper invokes to argue the predicted network is biologically consistent."}],"review_version":1}